217 related articles for article (PubMed ID: 10469011)
1. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
[TBL] [Abstract][Full Text] [Related]
2. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
[TBL] [Abstract][Full Text] [Related]
3. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
Faccenda E; Melmed S; Bevan JS; Eidne KA
Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.
Ruebel KH; Jin L; Zhang S; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(3):281-9. PubMed ID: 11740049
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16(INK4A) gene in human pituitary tumours.
Machiavelli G; Cotignola J; Danilowicz K; Carbonara C; Paes de Lima A; Basso A; Bruno OD; Szijan I
Pituitary; 2008; 11(1):71-5. PubMed ID: 18058237
[TBL] [Abstract][Full Text] [Related]
7. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24.
Yamasaki H; Mizusawa N; Nagahiro S; Yamada S; Sano T; Itakura M; Yoshimoto K
Clin Endocrinol (Oxf); 2003 Apr; 58(4):464-70. PubMed ID: 12641630
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.
Yoshino A; Katayama Y; Ogino A; Watanabe T; Yachi K; Ohta T; Komine C; Yokoyama T; Fukushima T
J Neurooncol; 2007 Jun; 83(2):153-62. PubMed ID: 17216555
[TBL] [Abstract][Full Text] [Related]
9. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
10. Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation.
Woloschak M; Yu A; Post KD
Mol Carcinog; 1997 Aug; 19(4):221-4. PubMed ID: 9290697
[TBL] [Abstract][Full Text] [Related]
11. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
Kaltsas GA; Kola B; Borboli N; Morris DG; Gueorguiev M; Swords FM; Czirják S; Kirschner LS; Stratakis CA; Korbonits M; Grossman AB
Clin Endocrinol (Oxf); 2002 Oct; 57(4):443-8. PubMed ID: 12354125
[TBL] [Abstract][Full Text] [Related]
12. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M
J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177
[TBL] [Abstract][Full Text] [Related]
13. Increased MEN1 mRNA expression in sporadic pituitary tumours.
McCabe CJ; Gittoes NJ; Sheppard MC; Franklyn JA
Clin Endocrinol (Oxf); 1999 Jun; 50(6):727-33. PubMed ID: 10468944
[TBL] [Abstract][Full Text] [Related]
14. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis.
Poncin J; Stevenaert A; Beckers A
Eur J Endocrinol; 1999 Jun; 140(6):573-6. PubMed ID: 10366412
[TBL] [Abstract][Full Text] [Related]
15. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the MEN1 gene in sporadic pituitary adenomas.
Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the p16INK4A gene by methylation is not a frequent event in sporadic ovarian carcinoma.
Brown I; Milner BJ; Rooney PH; Haites NE
Oncol Rep; 2001; 8(6):1359-62. PubMed ID: 11605066
[TBL] [Abstract][Full Text] [Related]
19. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours.
Antonini SR; Latronico AC; Elias LL; Cukiert A; Machado HR; Liberman B; Mendonca BB; Moreira AC; Castro M
Clin Endocrinol (Oxf); 2002 Nov; 57(5):657-62. PubMed ID: 12390341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
